1-8 of 8
Mauro P. Avanzi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Primary Analysis of Zuma-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL)

Free
Caron Jacobson, MD MMSc, Julio C. Chavez, MD, Alison R. Sehgal, MD, Basem M. William, MDMRCP, Javier Munoz, MD, Gilles Salles, MDPhD, Pashna N. Munshi, MD, Carla Casulo, MD, David Maloney, MD PhD, Sven de Vos, MD PhD, Ran Reshef, MD, Lori A. Leslie, MD, Ibrahim Yakoub-Agha, Olalekan O. Oluwole, MBBS, MPH, Henry C.H. Fung, MD, Joseph D. Rosenblatt, MD, John M. Rossi, MS, Lovely Goyal, PhD, Vicki Plaks, LLB, PhD, Yin Yang, MS, Jennifer Lee, BS, Wayne Godfrey, MD, Remus Vezan, MD PhD, Mauro P. Avanzi, MD PhD, Sattva S. Neelapu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–41.
https://doi.org/10.1182/blood-2020-136834
Published: 2020
Journal Articles

Retreatment With Axicabtagene Ciloleucel (Axi-Cel) in Patients With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma in ZUMA-5

Free
Julio C. Chavez, MD, Caron A. Jacobson, MD, Alison R. Sehgal, MD, Sattva S. Neelapu, MD, David G. Maloney, MD PhD, Gilles Salles, MD PhD, Basem M. William, MDMRCP, Yin Yang, MS, Lovely Goyal, PhD, Justin Chou, PhD, Vicki Plaks, LLB, PhD, Mauro P. Avanzi, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 34.
https://doi.org/10.1182/blood-2020-135871
Published: 2020
Journal Articles

End of Phase 1 Results from Zuma-6: Axicabtagene Ciloleucel (Axi-Cel) in Combination with Atezolizumab for the Treatment of Patients with Refractory Diffuse Large B Cell Lymphoma

Free
Caron A. Jacobson, MD MMSc, Frederick L. Locke, MD, David B. Miklos, MD PhD, Alex F. Herrera, MD, Jason R. Westin, MD, Jennifer Lee, John M. Rossi, MS, Lianqing Zheng, PhD, Mauro P. Avanzi, MD, Zachary J. Roberts, MD, PhD, Jennifer Sun, MS
Journal: Blood
Blood (2018) 132 (Supplement 1): 4192.
https://doi.org/10.1182/blood-2018-99-111523
Published: 2018
Journal Articles

IL-18 Secreting CAR T Cells Enhance Cell Persistence, Induce Prolonged B Cell Aplasia and Eradicate CD19+ Tumor Cells without Need for Prior Conditioning

Free
Mauro P. Avanzi, MD PhD, Dayenne G. van Leeuwen, Xinghuo Li, Kenneth Cheung, Hyebin Park, Terence J. Purdon, Renier J. Brentjens, MD PhD
Journal: Blood
Blood (2016) 128 (22): 816.
https://doi.org/10.1182/blood.V128.22.816.816
Published: 2016
Journal Articles

Actin and Myosin-II Inhibition Increase Megakaryocyte Proplatelet Formation Through a Caspase Dependent Mechanism

Free
Mauro P. Avanzi, MD, Oluwasijibomi E. Oluwadara, W. Beau Mitchell, MD
Journal: Blood
Blood (2013) 122 (21): 3652.
https://doi.org/10.1182/blood.V122.21.3652.3652
Published: 2013
Journal Articles

C-MYC and NF-E2 Genes Regulate Proplatelet Formation in Cultured Megakaryocytes with Different Levels of Polyploidization.

Free
Mauro P. Avanzi, MD, Jennifer G. Davila, MD, Francine Goldberg, W. Beau Mitchell, MD
Journal: Blood
Blood (2012) 120 (21): 2289.
https://doi.org/10.1182/blood.V120.21.2289.2289
Published: 2012
Journal Articles

The Immunologic Role of Platelets in Sickle Cell Disease Pathophysiology

Free
Jennifer G. Davila, MD, Mauro P. Avanzi, MD, Francine Goldberg, W. Beau Mitchell, MD
Journal: Blood
Blood (2012) 120 (21): 1015.
https://doi.org/10.1182/blood.V120.21.1015.1015
Published: 2012
Journal Articles

Optimizing Megakaryocyte Polyploidization in Culture by Targeting Multiple Pathways of Cytokinesis

Free
Mauro P. Avanzi, MD, Amanda Chen, Alexandra Haugh, W. Beau Mitchell, MD
Journal: Blood
Blood (2011) 118 (21): 4820.
https://doi.org/10.1182/blood.V118.21.4820.4820
Published: 2011